BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan · Delayed Price · Currency is JPY 62.00
-2.00 (-3.13%)
Jul 25, 2025, 3:30 PM JST
TYO:4594 Revenue
In the fiscal year ending March 31, 2025, BrightPath Biotherapeutics had annual revenue of 1.13M JPY with 1,473.61% growth. BrightPath Biotherapeutics had revenue of 12.00M in the quarter ending December 31, 2018, a decrease of -81.25%.
Revenue
1.13M
Revenue Growth
-99.71%
P/S Ratio
4,951.86
Revenue / Employee
26.98K
Employees
42
Market Cap
5.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.13M | 1.06M | 1,473.61% |
| Mar 31, 2024 | 72.00K | -353.93M | -99.98% |
| Mar 31, 2018 | 354.00M | -175.00M | -33.08% |
| Mar 31, 2017 | 529.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition